Cyanotech Announces Discovery of Vitamin K2 in Hawaiian Spirulina Pacifica®
— One serving provides 94% RDI of Vitamin K —
KAILUA KONA, Hawaii (December 10, 2009) — Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health products, today announced its Hawaiian Spirulina Pacifica® has achieved another nutritional first. Already the most nutritious Spirulina in the world, it is also a good source of Vitamin K2.
"The discovery of Vitamin K2 in Hawaiian Spirulina Pacifica is exciting and further supports its nutritional superiority,” said Andrew H. Jacobson, President and CEO of Cyanotech. “Analytical results from an independent contract laboratory indicate that Hawaiian Spirulina Pacifica provides approximately 15 mcg / 3g serving size or 19% of the Daily Recommended Value.”
Vitamin K2 is one form of Vitamin K. Although less well known, Vitamin K2 has long been linked to blood health because about half of the 16 known proteins that depend on the vitamin are necessary for blood coagulation. Recent studies cited in the American Journal of Clinical Nutrition reveal that Vitamin K2 can have positive effects on alleviating osteoporosis and cardiovascular diseases. In bone, Vitamin K2 activates a critical protein required to bind calcium, thus strengthening the skeleton. In circulation, Vitamin K2 participates in activation of the most potent inhibitor of arterial calcification, lowering the risk of vascular damage. In addition, exciting new research is showing that Vitamin K2 may be beneficial for Alzheimer's disease, a variety of cancers, varicose veins and skin aging.
Despite its importance for blood health, many multivitamins contain very little if any Vitamin K1 or K2. Hawaiian Spirulina Pacifica naturally contains sufficient Vitamin K2 (menaquinones) and Vitamin K1
(phylloquinones) to provide 75 mcg / 3g serving size or 94% of the Recommended Daily Intake, an excellent source of Vitamin K. In fact, Hawaiian Spirulina Pacifica provides more Vitamin K in a 3-gram serving
size (94% DV) than one cup of Romaine Lettuce or Endive (70% DV).
Mr. Jacobson concluded that “This is a very important nutrient and confirms that Hawaiian Spirulina Pacifica should be a part of healthy diets everywhere.”
About Cyanotech — Cyanotech Corporation, a world leader in microalgae technology, produces BioAstin® Natural Astaxanthin and Hawaiian Spirulina Pacifica®—all natural, functional nutrients that leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. Cyanotech's Spirulina products offer complete nutrition, and augment energy and immune response. They are FDA reviewed and accepted as Generally Recognized as Safe (GRAS) for use in food products. BioAstin's superior antioxidant activity and ability to support and maintain a natural anti-inflammatory response enhance skin, muscle and joint health. All Cyanotech products are produced from microalgae grown at its 90-acre facility in Kona, Hawaii using patented and proprietary technology. Cyanotech distributes to nutritional supplement, nutraceutical and cosmeceutical manufacturers and marketers in more than 40 countries worldwide. Cyanotech was the first microalgae company in the world to obtain quality management standards ISO 9001:2000 certification and is GMP-certified by the Natural Products AssociationTM. Visit www.cyanotech.com for more information.
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995
Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, forecasts of sales in future periods, changes in sales levels to our largest customers, weather patterns, production problems caused by contamination, risks associated with the acceptance of new products, competition, foreign exchange fluctuations, government regulation, and other factors more fully detailed in the Company’s recent Form 10-Q and annual Form 10-K filings with the Securities and Exchange Commission.
Bruce Russell: email@example.com
(310) 559-4955 x101